VEGFC in relation to OS and EFS in pediatric AML. The 100 pediatric patients with AML were split in a group with high VEGFC (ie, above the median VEGFC level; n = 50) and a group with low VEGFC (ie, below the median VEGFC level; n = 50) mRNA expression levels. Kaplan-Meier plots show the OS (A) and EFS (B) of pediatric AML patient subgroups with high versus low transcript levels of VEGFC.